Differences in Ischemic and Hemorrhagic Recurrence Rates among Race-Ethnic Groups in the PRoFESS Secondary Stroke Prevention Trial

Abstract

Background and Aims

Epidemiological studies show that vascular risk factors are the same across the world but their effect vary between different race-ethnic groups. However, few studies have evaluated differences in recurrent stroke rates in various race-ethnicities. In >20 000 patients spanning 35 countries encompassing most race-ethnicities, we evaluated the incidence of ischemic and hemorrhagic strokes and myocardial infarction in patients within the context of the largest secondary stroke prevention trial (Prevention Regimen for Effectively Avoiding Secondary Strokes) to identify any significant differences.

Methods

There were 20 332 patients with a recent ischemic stroke randomized in a factorial design to receive the antiplatelet agent clopidogrel vs. aspirin plus extended-release dipyridamole, and 80 mg of the anthypertensive telmisartan vs. placebo. The primary outcome for the trial was the time to any recurrent stroke. Statistical analysis was used to detect race-ethnic differences in recurrent vascular events.

Results

Mean patient age was 66 (±8·6) years and 36% were women. The study included 58% European/Caucasian, 33% Asians, 5% Latin/Hispanic, and 4% Black African. There were 74% of patients that were hypertensive, and average systolic and diastolic blood pressure was 144·1/83·8 mmHg. There was at least one significant difference in the overall test of all race-ethnic groups in myocardial infarction and symptomatic intracerebral hemorrhage occurrence. In the Kaplan–Meier hemorrhage and stroke-free survival curves, Asians showed a significantly higher recurrence of ischemic stroke risk in the 135–150 mmHg and greater than 150 mm Hg blood pressure groups, and a greater risk of hemorrhage recurrence in the greater than 150 mmHg blood pressure group.

Conclusions

We found a significant difference in myocardial infarction and symptomatic intracerebral hemorrhage recurrence among different race-ethnic groups. The risk of recurrent ischemic and hemorrhagic stroke was greater in Asians with high blood pressure.

Keywords

cerebrovascular disease race-ethnicity stroke vascular recurrence

Get full access to this article

View all access options for this article.

References

Sacco

Diener

Yusuf

. Aspirin and extended release dipyridamole versus clopidogrel for recurrent stroke. New Engl J Med 2008; 359:1238–51.

Sacco

Boden-Albala

Abel

. Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan Stroke Study. Stroke 2001; 32:1725–31.

Mc Gruder

Malarcher

Antoine

Greenlund

Croft

. Racial and ethnic disparities in cardiovascular Risk factors among stroke survivors (USA 1999–2001). Stroke 2004; 35:1557–61.

Sacco

Kaufman

Zamanillo

. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke 1995; 26:14–20.

Feldmann

Daneault

Kwan

. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40:1541–5.

Caplan

Gorelick

Hier

. Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986; 17:648–55.

Inzitari

Hachinski

Taylor

Barnett

HJM

. Racial differences in the anterior circulation in cerebrovascular disease: how much can be explained by risk factors? Arch Neurol 1990; 47:1080–4.

Waddy

Cotsonis

Lynn

. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke 2009; 40:719–25.

Diener

Sacco

Yusuf

. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis 2007; 23:368–80.

10.

Yusuf

Diener

Sacco

. Telmisartan to prevent recurrent stroke and cardiovascular events. New Engl J Med 2009; 359:1225–37.

11.

Estol

Bath

Gorelick

Cotton

Martin

Weber

. Blood pressure control variations among different race-ethnic groups in the PRoFESS Study. Blood Press Monit 2014 (in press).

12.

Wong

Haung

Gao

Lam

WWM

Chan

. Cerebrovascular disease among Chinese populations – recent epidemiological and neuroimaging studies. Hong Kong Med J 2001; 7:50–7.

13.

Morikawa

Nakagawa

Naruse

. Trends in stroke incidence and acute case fatality in a Japanese rural area – the oyabe study. Stroke 2000; 31:1583–7.

14.

Sheng

Chu

Lan

Chiang

. Incidence of stroke in Taiwan. Stroke 1992; 23:1237–41.

15.

Cheng

Ziegler

Lai

. Stroke in China, 1986 through 1990. Stroke 1995; 26:1990–4.

16.

Nguyen-Huynh

Johnston

. Regional variation in hospitalization for stroke among Asians/Pacific Islanders in the United States: a nationwide retrospective cohort study. BMC Neurol 2005; 5:21.

17.

Nogales-Gaete

Núñez

Arriagada

. Caracterización clínica de 450 pacientes con enfermedad cerebrovascular ingresados a un hospital público durante 1997. Rev Med Chil 2000; 128:1227–36.

18.

Del Brutto

Mosquera

Sánchez

Santos

Noboa

. Stroke subtypes among hispanics living in Guayaquil, Ecuador: results from the Luis Vernaza Hospital stroke registry. Stroke 1993; 24:1833–6.

19.

Estol

Esnaola

. Stroke in Argentina. Int J Stroke 2010; 5:35–9.

20.

Gorelick

Wong

Bae

Pandey

. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008; 39:2396–9.

21.

Ovbiagele

Diener

Yusuf

. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 2011; 306:2137–44.